These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 10449753)

  • 1. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C; Friedman JM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor.
    Carpenter LR; Farruggella TJ; Symes A; Karow ML; Yancopoulos GD; Stahl N
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6061-6. PubMed ID: 9600917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of activation of the protein tyrosine phosphatase SHP-2 by the human leptin receptor.
    Löthgren A; McCartney M; Rupp Thuresson E; James SR
    Biochim Biophys Acta; 2001 Feb; 1545(1-2):20-9. PubMed ID: 11342028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
    Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
    Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
    Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA; Waxman DJ
    J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent roles of SHP-2 in ERK activation by leptin receptors.
    Bjørbaek C; Buchholz RM; Davis SM; Bates SH; Pierroz DD; Gu H; Neel BG; Myers MG; Flier JS
    J Biol Chem; 2001 Feb; 276(7):4747-55. PubMed ID: 11085989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
    Zhang S; Mantel C; Broxmeyer HE
    J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
    Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
    J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation.
    Blanchette J; Racette N; Faure R; Siminovitch KA; Olivier M
    Eur J Immunol; 1999 Nov; 29(11):3737-44. PubMed ID: 10556830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.